Literature DB >> 8210340

Increased expression of the epidermal growth factor receptor in human epidermal keratinocytes after exposure to ionizing radiation.

R U Peter1, A Beetz, C Ried, G Michel, D van Beuningen, T Ruzicka.   

Abstract

The effect of exposure of human epidermal keratinocytes to ionizing radiation, both in vivo and in vitro, on the expression of the epidermal growth factor receptor (EGF-R) was studied on the protein, mRNA, and functional levels. Quantitative fluorometry of short-term organ cultures incubated with a monoclonal antibody against human EGF-R revealed a dose-dependent increase of EGF-R expression 24 h after irradiation with 4 and 6 Gy, with an additional increase after 48 h. In biopsy specimens from patients undergoing radiation therapy a markedly increased expression could be determined by quantitative fluorometry during radiation therapy which wa still considerably above the baseline level 4 weeks after termination of treatment. Radioligand binding assays demonstrated a 50% increase in 125I-EGF binding to primary keratinocytes and A431 cells, at doses of 1 Gy, with a further increase after 72 and 96 h. Northern blots were performed with total RNA from two human epidermal cell lines (SCLII and A431). In A431 cells, increased EGF-R transcript levels could be detected 48 h after irradiation. In cells of the SCLII cell line, EGF-R expression was not affected by irradiation. These results were confirmed by semiquantitative polymerase chain reaction of primary cultured keratinocytes, demonstrating an increase of transcripts of EGF-R 24 h after irradiation with single doses of 6 Gy. Thus exposure to ionizing radiation leads to an increased expression of functionally intact EGF-R in human keratinocytes, at the protein and mRNA levels, both in vitro and in vivo; we hypothesize that this effect is part of a stress program of epidermal cells in response to ionizing radiation, ensuring rapid repopulation of irradiated areas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8210340

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  12 in total

1.  Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer.

Authors:  Tim J Kruser; Eric A Armstrong; Amol J Ghia; Shyhmin Huang; Deric L Wheeler; Robert Radinsky; Daniel J Freeman; Paul M Harari
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

2.  The clinical features and pathophysiology of acute radiation dermatitis in patients receiving tomotherapy.

Authors:  Ji Hyun Lee; Chul Seung Kay; Lee So Maeng; Se Jeong Oh; An Hi Lee; Jeong Deuk Lee; Chi Wha Han; Sang Hyun Cho
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

Review 3.  [Cutaneous radiation syndrome after accidental skin exposure to ionizing radiation].

Authors:  R U Peter
Journal:  Hautarzt       Date:  2013-12       Impact factor: 0.751

4.  The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy.

Authors:  Somaira Nowsheen; James A Bonner; Eddy S Yang
Journal:  Radiother Oncol       Date:  2011-06-28       Impact factor: 6.280

Review 5.  EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection.

Authors:  Kyle C Cuneo; Mukesh K Nyati; Dipankar Ray; Theodore S Lawrence
Journal:  Pharmacol Ther       Date:  2015-07-21       Impact factor: 12.310

6.  Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck.

Authors:  Francesco Perri; Francesco Longo; Franco Ionna; Francesco Caponigro
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

7.  The use of recombinant human epidermal growth factor to promote healing for chronic radiation ulcer.

Authors:  Sang-wook Lee; Sue Young Moon; Yeun Hwa Kim; Joon Pio Hong
Journal:  Int Wound J       Date:  2007-09       Impact factor: 3.315

Review 8.  Immunotoxin therapy for CNS tumor.

Authors:  Edward Rustamzadeh; Walter C Low; Daniel A Vallera; Walter A Hall
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

Review 9.  Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme.

Authors:  Edward Rustamzadeh; Chunbin Li; Sekou Doumbia; Walter A Hall; Daniel A Vallera
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130

10.  EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?

Authors:  A Paliga; R Onerheim; A Gologan; G Chong; A Spatz; T Niazi; A Garant; D Macheto; T Alcindor; T Vuong
Journal:  Br J Cancer       Date:  2012-10-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.